Skip to Main Content

Paper Details

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Clin Cancer Res
60
2014

Datasets

Release 1.2